Sunday, 25 August 2019

China News

  • Consumers are winners in the BRCA gene case

    China |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jul, 2013

    In the wake of US Supreme Court's win-win verdict in Association for Molecular Pathology vs Myriad Genetics case, Frost and Sullivan life sciences industry analysts, Mr Justin Collishaw and...Read more

  • Stem cell scientist sues Nobel Prize assembly

    China |  News | By BioSpectrum Bureau  | 0 Comment | 07 Dec, 2012

    Singapore: Dr Rongxiang Xu, the founder of 'human body regenerative restoration science' and a renowned medical scientist, filed a lawsuit against the Nobel Assembly at Karolinska Institut...Read more

  • Chugai Pharma enters China Medical City

    China |  News | By BioSpectrum Bureau  | 0 Comment | 31 Dec, 2013

    Singapore: Chugai Pharmaceutical has announced that it has signed an agreement with the Taizhou Medical High-Tech Industrial Development Zone, a special economic zone in Taizhou, Jiangsu Pr...Read more

  • Promega opens new facility in Shanghai

    China |  News | By BioSpectrum Bureau  | 0 Comment | 19 Nov, 2012

    Singapore: Promega opened a new facility in Shanghai for its China operations. The new site for Shanghai Promega Biological Products replaces an existing molecular biology reagent productio...Read more

  • Tianyin Pharma Qionglai facility will be ready by April

    China |  News | By BioSpectrum Bureau  | 0 Comment | 08 Apr, 2013

    Singapore: Tianyin Pharmaceutical revealed that the progress made in the construction of its Qionglai facility (QLF) is in accordance with its schedule. After meeting several progress mile...Read more

  • Lilly expands partnership with Novast

    China |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jun, 2012

    Singapore: In support of its commitment to maximize growth opportunities in China, Eli Lilly has decided to increase its network of manufacturing capabilities in this key emerging market co...Read more

  • China to reduce prices of drugs by up to 20%

    China |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 09 Jan, 2013

    Singapore: After India, now China has decided to cut prices of about 400 drugs for respiratory diseases, fever and pain by up to 20 percent from February 1, 2013. This decision was taken ...Read more

  • First-ever fusion cage launched in China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 22 Aug, 2012

    Singapore: Bonovo Orthopedics launched the first PEEK (PEEK-OPTIMA polymer from INVIBIO) lateral interbody fusion cage, Cross-Fuse in China. Minimally invasive lateral interbody fusion (MIL...Read more

  • Celsion, Hisun Pharma enter tech development deal

    China |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jan, 2013

    Singapore: Celsion, a leading oncology drug development company, and Zhejiang Hisun Pharmaceutical, a leading Chinese pharmaceutical company, have entered into a technology development agr...Read more

  • Consistent clinical trial quality is key for China

    China |  Opinion | By BioSpectrum Bureau  | 0 Comment | 05 Sep, 2013

    China's pharmaceutical market has grown steadily in the last few years and is projected to grow by an average 19 percent year-on-year over the next few years, according to Economic Intell...Read more

  • Kimball's China facility achieves ISO certification

    China |  News | By BioSpectrum Bureau  | 0 Comment | 02 Aug, 2013

    Singapore: Kimball Electronics Group, a subsidiary of Kimball International, announced that the company's production facility in Nanjing, China, has achieved the stringent ISO 13485 certifi...Read more

  • GSK research paper on China retracted

    China |  News | By BioSpectrum Bureau  | 0 Comment | 10 Dec, 2013

    Singapore: British drug maker GlaxoSmithKline that has been surrounded by unending controversy for allegations made against the company's operations in China has now released a statement. ...Read more

  • Li Xiting appointed CEO of Mindray

    China |  News | By BioSpectrum Bureau  | 0 Comment | 28 Nov, 2012

    Singapore: Mr Xu Hang has resigned from the position of co-chief executive officer (co-CEO) at Mindray Medical International. Mr Xu Hang will, however, remain the company's chairman. Mr Li ...Read more

  • ProMetic to get $10 mn equity from Chinese firm

    China |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jan, 2013

    Singapore: ProMetic Life Sciences has finalized the $10 million strategic equity investment by Shenzhen Hepalink Pharmaceutical pursuant to the terms and conditions previously disclosed on...Read more

  • Bioplasma World Asia 2012 to be held in July

    China |  News | By BioSpectrum Bureau  | 0 Comment | 22 May, 2012

    Singapore: Recognizing the region's need to work towards self-sufficiency in plasma products, Bioplasma World Asia 2012 will bring together the Asian and international blood plasma communit...Read more

  • Chugai gives cancer drug license to Debiopharm

    China |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jan, 2013

    Singapore: Chugai Pharmaceutical and Debiopharm Group entered into a licensing agreement regarding FF284 (called Debio 1347 by Debiopharm), which was discovered by Chugai and is about to e...Read more

  • ASKLEP joins Medidata partner program

    China |  News | By BioSpectrum Bureau  | 0 Comment | 20 Dec, 2012

    Singapore: ASKLEP, a leading Tokyo-based provider of clinical research services, has joined the Medidata Solutions Partner Program as part of its strategy to expand its existing offerings ...Read more

  • Medistem in collaboration with China firm subsidiary

    China |  News | By BioSpectrum Bureau  | 0 Comment | 11 Oct, 2012

    Singapore: US-based Medistem has entered into a collaboration with Superview Biotechnology, a subsidiary of Yinhuan Holding from Yixing, China. The joint work will be aimed at using proprie...Read more



Podcast

 

Survey Box

Will APAC lead the way for innovation in the field of precision medicine?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls